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Volume 53, Number 17S Abstracts 83SConclusions: Upregulation of TLR2 and HMGB-1
expression occurs in ischaemic muscle. Activation of
TLR2 signaling leads to IL-6 release which may contrib-
ute to inflammation and muscle damage. HMGB-1 inhi-
bition may be a potential target in reducing skeletal
muscle damage in CLI.
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Objectives: Human saphenous vein (HSV) is the
most widely used arterial bypass conduit despite a high
rate of intimal hyperplasia (IH). IH is thought to evolve
as a response to vascular injury. We investigated whether
injury from back-table surgical preparation impairs HSV
endothelial and smooth muscle function.
Methods: HSV segments were collected from patients
undergoing arterial bypass. HSV was collected after surgi-
cal removal but before manipulation (unmanipulated,
UM). Additional HSV was collected after back-table ma-
nipulation, which included hand-held syringe distention
and marking for orientation (after manipulation, AM).
Paired UM and AM segments were obtained from 15
patients. HSV rings were suspended in amuscle bath. Force
measurements were obtained after administration of phen-
ylephrine (PE), sodium nitroprusside (SNP), and carbachol
(CCH).
Results: PE induced mean force of 0.070.04
N/m^2 in UM-HSV, versus 0.030.04 in AM-HSV
(p0.001). SNP induced smooth muscle dependent
relaxation of 53.923.9% in UM-HSV, versus
21.416.6 in AM-HSV (p0.0001, Figure). CCH in-
duced endothelial dependent relaxation of 19.912.5%
in UM-HSV, versus 0.76.3 in AM-HSV (p0.001,
Figure).
Conclusions: Back-table preparation causes injury
which markedly decreases HSV endothelial and smooth
muscle function. This argues for less injurious means of
distending and marking HSV grafts.
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Objectives: Gene therapy shows promise in the treat-
ent of vascular disease, but a formidable challenge has
een delivery of genetic material in a safe and non-toxic
ay. Viral transfection comes with significant clinical impli-
ations in terms of safety, and there are still no FDA-
pproved gene therapy products. This has led to recent
nterest in developing alternatives to viral transfection that
re low risk, predictable, and non-toxic. Biodegradable
olymers have shown promise as one of these alternatives,
ut to date have been exclusively tested in human stem
ells. Differentiated cell types would be prime targets for
herapeutic gene modulation in the prevention of various
isease processes. We aim to establish polymeric transfec-
igure. Percent relaxation of UM versus AM HSV in response to
NP (p0.0001), and CCH (p0.001).ion as a method of gene therapy in cells of vascular origin.
